ACAD
35.67
+1.5
+4.39%
AEMD
0.196
-0.01
-4.6341%
APRI
1.6
0.00
0.00%
ARNA
4.34
-0.02
-0.46%
ATEC
1.42
0.00
0.00%
CNAT
5.93
-0.02
-0.34%
CRXM
0.495
-0.006
-1.198%
CYTX
0.865
-0.01
-1.1200%
DXCM
67.12
-0.45
-0.67%
GNMK
10.11
+0.51
+5.31%
HALO
15.79
+0.92
+6.19%
ILMN
191.23
+6.98
+3.79%
INNV
0.153
+0.008
+5.1724%
INO
8.42
+0.26
+3.19%
ISCO
0.058
+0.001
+2.2807%
ISIS
58.24
+1.52
+2.68%
LGND
79.8
+2.16
+2.78%
LPTN
2.06
+0.04
+1.98%
MBVX
2.8
-0.07
-2.44%
MEIP
1.99
0.00
0.00%
MNOV
3.82
-0.06
-1.55%
MRTX
27.01
-0.78
-2.81%
MSTX
0.52
+0.014
+2.8261%
NBIX
35.51
+1.42
+4.17%
NUVA
44.65
-0.08
-0.18%
ONCS
0.27
0.00
+1.50%
ONVO
4.77
+0.23
+5.07%
OREX
6.67
+0.1
+1.52%
OTIC
27.91
+1.67
+6.36%
QDEL
23.18
-0.12
-0.52%
RCPT
156.4
+9.06
+6.15%
RGLS
13.47
+0.92
+7.33%
RMD
64.78
+0.84
+1.31%
SCIE
0.022
+0.001
+4.762%
SPHS
0.696
-0.044
-5.9849%
SRNE
10.35
+1.33
+14.75%
TROV
8.51
+0.76
+9.81%
VICL
0.92
-0.03
-3.16%
VOLC
17.99
0.00
0.00%
ZGNX
1.43
+0.04
+2.88%
ACAD
35.67
+1.5
+4.39%
AEMD
0.196
-0.01
-4.6341%
APRI
1.6
0.00
0.00%
ARNA
4.34
-0.02
-0.46%
ATEC
1.42
0.00
0.00%
CNAT
5.93
-0.02
-0.34%
CRXM
0.495
-0.006
-1.198%
CYTX
0.865
-0.01
-1.1200%
DXCM
67.12
-0.45
-0.67%
GNMK
10.11
+0.51
+5.31%
HALO
15.79
+0.92
+6.19%
ILMN
191.23
+6.98
+3.79%
INNV
0.153
+0.008
+5.1724%
INO
8.42
+0.26
+3.19%
ISCO
0.058
+0.001
+2.2807%
ISIS
58.24
+1.52
+2.68%
LGND
79.8
+2.16
+2.78%
LPTN
2.06
+0.04
+1.98%
MBVX
2.8
-0.07
-2.44%
MEIP
1.99
0.00
0.00%
MNOV
3.82
-0.06
-1.55%
MRTX
27.01
-0.78
-2.81%
MSTX
0.52
+0.014
+2.8261%
NBIX
35.51
+1.42
+4.17%
NUVA
44.65
-0.08
-0.18%
ONCS
0.27
0.00
+1.50%
ONVO
4.77
+0.23
+5.07%
OREX
6.67
+0.1
+1.52%
OTIC
27.91
+1.67
+6.36%
QDEL
23.18
-0.12
-0.52%
RCPT
156.4
+9.06
+6.15%
RGLS
13.47
+0.92
+7.33%
RMD
64.78
+0.84
+1.31%
SCIE
0.022
+0.001
+4.762%
SPHS
0.696
-0.044
-5.9849%
SRNE
10.35
+1.33
+14.75%
TROV
8.51
+0.76
+9.81%
VICL
0.92
-0.03
-3.16%
VOLC
17.99
0.00
0.00%
ZGNX
1.43
+0.04
+2.88%
Home » Events, SDBN Blog, SDBN Events

SDBN August Event: The Transformation of the Biotech Business Model

Submitted by on August 11, 2009 – 5:10 pm

Our August event will feature an interactive panel in which we’ll discuss the areas you are interested in hearing about: Green technology, Translational Research/Medicine, and Drug Development.

Transformation of Biotech Panel Members:

* Aileen Alvarado-Swaisgood, President, Molecular Alliance (moderator)
* Nigel Beeley, CEO, ENRQI
* Roy Cosan, Director, Strategic Planning & Alliance Management, External Research and Early Development, Johnson & Johnson PRD
* Ali Esteghlalian, Product Manager, Industrial Enzymes & Principal Scientist, Enzyme Applications, Verenium
* Gary Firestein, Professor of Medicine, Chief, Division of Rheumatology Allergy & Immunology, Dean, Translational Medicine, UCSD
* Bruce Steel, Chief Business Officer, Anaphore

[[Click Here For More Information]]

Leave a comment!

Add your comment below, or trackback from your own site. You can also Comments Feed via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:

<a href="" title="" rel=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong> 

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.


nine × 1 =